Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CG Oncology, Inc. - Common stock
(NQ:
CGON
)
41.00
+4.80 (+13.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
819,590
Open
36.93
Bid (Size)
38.10 (2)
Ask (Size)
47.00 (1)
Prev. Close
36.20
Today's Range
36.49 - 41.21
52wk Range
28.55 - 50.23
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024
April 26, 2024
Company to host virtual investor event on Friday, May 3, 2024, at 4:30pm EDT following presentation of results from the Phase 3 BOND-003 trial at the 2024 AUA Annual Meeting
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
April 24, 2024
- Final results of CORE-001 Phase 2 trial of cretostimogene in combination with pembrolizumab for the treatment of BCG-unresponsive NMIBC -
From
CG Oncology Inc.
Via
GlobeNewswire
Performance
YTD
+3.41%
+3.41%
1 Month
N/A
N/A
3 Month
+17.04%
+17.04%
6 Month
+3.41%
+3.41%
1 Year
+3.41%
+3.41%
More News
Read More
IPO Stocks: Will Reddit Unplug The Bulging U.S. IPO Pipeline?
March 28, 2024
Via
Investor's Business Daily
Topics
Initial Public Offering
Exposures
Securities Market
CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting
March 28, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder Cancer
February 27, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
Everyone's Talking About These 2 Biotech IPO Stocks, But Are They Buys?
February 25, 2024
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
3 attractive stocks that insiders are buying
February 12, 2024
Via
MarketBeat
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
February 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
January 30, 2024
From
CG Oncology, Inc.
Via
Business Wire
KKR-Backed BrightSpring Prices Below Expectations, Then Opens Lower
January 28, 2024
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
KLA Reports Q2 Results, Joins Visa, Western Digital And Other Big Stocks Moving Lower In Friday's Pre-Market Session
January 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.